Drug Interactions Between Paracetamol and Setrons in Pain Management

Overview

The aim of this study is to demonstrate that the association paracetamol / ondansetron is not as effective as the association paracetamol / droperidol in the treatment of pain in children following tonsillectomy. The secondary objectives are to compare opioid consumption (morphine / codeine) and the cumulated incidence of nausea and vomiting between the two groups of patients in the first 24 hours after

Full Title of Study: “Paracetamol and Setrons : Drug Interactions in the Management of Pain After Tonsillectomy in Children”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: June 2012

Detailed Description

Tonsillectomy is a common operation performed in children that is associated with marked pain and a high incidence of nausea and vomiting. Therefore, national and international guidelines have recommended the use of a setron as a prevention to nausea and vomiting and also the systematic administration of paracetamol to help in the control of postoperative pain. However, a potential interaction between setrons and paracetamol has been reported in different animal studies and in human volunteers although its existence has never been found in the clinic. Indeed, several hypotheses are proposed to explain the mechanism of action of paracetamol in the treatment of pain. However, a recent one involves the endocannabinoid system and spinal serotonin receptors. Serotonin receptors are also involved in the mechanism of action of antiemetics such as setrons. Indeed, these drugs are serotonin antagonists. Therefore, the investigators hypothesized that the concomitant administration of paracetamol and ondansetron leads to an interaction that will decrease the analgesic effect of paracetamol. Patients aged 2-7 years old and scheduled for a tonsillectomy will be recruited. They will all receive intraoperatively intravenous paracetamol together with either ondansetron or droperidol. Pain scores using the CHEOPS scale will be recorded for 24 hours. Furthermore, patients will receive i.v. morphine during the operation and in the recovery room if necessary and a non-steroidal anti-inflammatory drug for postoperative pain; on the ward, oral codeine will be administered when needed. Pain scores will be recorded regularly for up to 24 hours together with opioid consumption and the incidence of nausea and vomiting in the same period. Any adverse event will also be recorded.

Interventions

  • Drug: paracetamol /droperidol
  • Drug: paracetamol / ondansetron

Arms, Groups and Cohorts

  • Active Comparator: comparateur
    • paracetamol / droperidol
  • Experimental: Eperimental
    • paracetamol / ondansetron

Clinical Trial Outcome Measures

Primary Measures

  • -pain scores
    • Time Frame: 4 hours after drug administration
    • pain scores at rest 4 hours after administration of paracetamol and ondansetron / droperidol intraoperatively

Secondary Measures

  • analgesic consumption
    • Time Frame: 24 hours after inclusion
    • analgesic consumption during 24 hours podt inclusion
  • incidence of nausea and vomiting.
    • Time Frame: data continuiousley collected during 24 hours
    • – incidence of nausea and vomiting.

Participating in This Clinical Trial

Inclusion Criteria

  • tonsillectomy in a child 2-7 years old who is hospitalized for at least 24 hours ; – informed consent from one parent at least Exclusion Criteria:

  • hospital stay of less than 24 hours ; – patient already on pain medication ; – allergic patient with a contra-indication to one of the study drugs.

Gender Eligibility: All

Minimum Age: 2 Years

Maximum Age: 7 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Limoges
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.